BerganKDV Wealth Management’s Novartis NVS Stock Holding History

BerganKDV Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$43.6K	Hold	432	–	–	﹤0.01%	392
2023 Q1	$39.7K	Hold	432	–	–	﹤0.01%	420
2022 Q4	$39.2K	Hold	432	–	–	﹤0.01%	403
2022 Q3	$33K	Sell	432 -196	-31%	-$16.2K	﹤0.01%	418
2022 Q2	$53K	Hold	628	–	–	0.01%	377
2022 Q1	$55K	Sell	628 -1,026	-62%	-$88.8K	0.01%	392
2021 Q4	$145K	Buy	1,654 +1,011	+157%	+$83.9K	0.02%	291
2021 Q3	$53K	Sell	643 -61	-9%	-$5.49K	0.01%	392
2021 Q2	$64K	Buy	704 +61	+9%	+$5.43K	0.01%	356
2021 Q1	$55K	Sell	643 -49	-7%	-$4.4K	0.01%	361
2020 Q4	$65K	Sell	692 -5,090	-88%	-$445K	0.01%	326
2020 Q3	$503K	Sell	5,782 -238	-4%	-$20.6K	0.08%	150
2020 Q2	$526K	Buy	6,020 +128	+2%	+$11K	0.09%	139
2020 Q1	$486K	Buy	5,892 +559	+10%	+$49.9K	0.1%	132
2019 Q4	$505K	Buy	5,333 +86	+2%	+$7.72K	0.09%	145
2019 Q3	$456K	Sell	5,247 -338	-6%	-$30.3K	0.09%	139
2019 Q2	$510K	Sell	5,585 -669	-11%	-$56.6K	0.1%	136
2019 Q1	$539K	Buy	6,254 +203	+3%	+$16.3K	0.11%	130
2018 Q4	$465K	Buy	6,051 +221	+4%	+$17.2K	0.11%	123
2018 Q3	$450K	Buy	5,830 +463	+9%	+$34.2K	0.1%	126
2018 Q2	$363K	Buy	5,367 +154	+3%	+$10.6K	0.08%	136
2018 Q1	$378K	Sell	5,213 -153	-3%	-$11.6K	0.1%	127
2017 Q4	$404K	Sell	5,366 -1,484	-22%	-$112K	0.1%	135
2017 Q3	$527K	Buy	6,850 +3,591	+110%	+$271K	0.13%	121
2017 Q2	$244K	Sell	3,259 -39	-1%	-$2.76K	0.07%	152
2017 Q1	$219K	Buy	3,298 +129	+4%	+$8.6K	0.07%	159
2016 Q4	$207K	Buy	+3,169	New	+$206K	0.07%	156

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BerganKDV Wealth Management's NVS Position: Q2 2023 in Review

BerganKDV Wealth Management held its Novartis (NVS) position steady in Q2 2023 at 432 shares worth $43.6K. The position accounts for ﹤0.01% of the portfolio, ranked #392.

BerganKDV Wealth Management first reported a position in NVS in Q4 2016 and has held it in 27 quarters since. The position peaked at $539K in Q1 2019. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.

BerganKDV Wealth Management held 432 shares of Novartis worth $43.6K as of Q2 2023.
BerganKDV Wealth Management left its Novartis share count unchanged in Q2 2023.
Novartis made up ﹤0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #392 holding.
BerganKDV Wealth Management first reported a position in Novartis in Q4 2016 and has held it in 27 quarters since.
BerganKDV Wealth Management's Novartis position peaked at $539K in Q1 2019.
1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.